Understanding Lambert-Eaton Myasthenic Syndrome (LEMS)

Receiving a diagnosis of Lambert-Eaton Myasthenic Syndrome (LEMS) can feel like entering an unfamiliar world. Because it is so rare, you may find that many doctors—including local neurologists—have never personally treated a case before ^[1]. It is completely normal to feel overwhelmed, but understanding the biology of what is happening in your body is the first step toward managing the condition effectively.

A Breakdown in Communication

At its core, LEMS is an autoimmune disorder, which means your immune system is mistakenly attacking a part of your own body ^[2]. In this case, the target is the “on-off switch” that tells your muscles to move.

To move a muscle, your brain sends an electrical signal down a nerve. When that signal reaches the end of the nerve (the presynaptic terminal), it needs to release a chemical called acetylcholine. This chemical crosses a tiny gap to the muscle and tells it to contract. For this release to happen, calcium must enter the nerve through specialized channels called voltage-gated calcium channels (VGCC) ^[2][3].

In LEMS, your body produces antibodies that reduce the number or function of these presynaptic P/Q-type calcium channels. Without enough calcium entering the nerve, not enough acetylcholine is released. The result is a weak “whisper” of a signal where there should be a “shout,” leaving your muscles unable to work at full strength ^[2][4].

Understanding the Rarity

If you feel like you are the only person you know with this condition, the statistics suggest you are likely correct. LEMS is classified as an ultra-rare disease:

• Incidence: Only about 0.09 to 0.30 new cases are diagnosed per million people each year ^[1].
• Prevalence: At any given time, only about 1 to 3 people out of every million are living with the condition ^[1][5].

Two Paths: Subtypes of LEMS

Doctors generally divide LEMS into two main categories based on what triggered the immune system to start producing these antibodies. Knowing which type you have is essential for planning your care.

1. Paraneoplastic LEMS (Cancer-Related)

In about 50% to 60% of cases, LEMS is triggered by an underlying cancer, most commonly small-cell lung cancer (SCLC) ^[3][6]. Cancer cells in the lungs often have the same calcium channels on their surface that your nerves do. When your immune system tries to fight the cancer, it accidentally learns to attack the healthy channels on your nerves as well ^[3].

• Who it affects: This type is more common in older adults and those with a history of smoking ^[1][7].
• Early Warning: LEMS symptoms often appear months or even years before a tumor is large enough to cause cancer-related symptoms. While this can lead to earlier detection in some people, a patient’s prognosis is ultimately determined by the cancer’s stage, tumor biology, and response to treatment ^[8][3]. Crucially, rigorous cancer screening is recommended for all LEMS patients, even when the initial risk seems low.

2. Autoimmune/Non-Paraneoplastic LEMS

In the remaining 40% to 50% of cases, there is no underlying tumor. The immune system begins attacking the calcium channels for reasons that aren’t fully understood, often in people who already have a tendency toward other autoimmune issues ^[3].

• Who it affects: This type can occur at any age, including in younger adults, and is not linked to smoking ^[1][9].
• Outlook: Unlike the cancer-related version, primary autoimmune LEMS generally does not shorten a person’s life expectancy ^[10][1].

Signs and Clues

The hallmark of LEMS is weakness that starts in the upper legs and hips, making it difficult to stand up from a chair or climb stairs ^[2]. A characteristic feature of LEMS is post-exercise facilitation: while most people get weaker with activity, LEMS patients may find their strength and reflexes briefly improve for a few seconds after tensing their muscles, because the repetitive effort forces a temporary buildup of calcium in the nerve ^[2][11].

You may also experience autonomic dysfunction—issues with the part of the nervous system that controls “automatic” functions—such as a persistent dry mouth, constipation, or blurred vision ^[4][10].

LEMS vs. Myasthenia Gravis (MG)

Because it is so rare, LEMS is often misdiagnosed as Myasthenia Gravis. While individual patients may vary, a typical comparison looks like this:

• Weakness Pattern: LEMS usually starts in the legs/hips; MG usually starts in the eyes (drooping lids) or face.
• Response to Activity: In LEMS, strength may temporarily improve after brief exercise; in MG, muscles rapidly fatigue with exercise.
• Autonomic Symptoms: Common in LEMS (dry mouth, constipation); rare in MG.
• Reflexes: Often reduced or absent in LEMS; usually normal in MG.